Kageaki Taima

Hirosaki, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

Cyclical Hemoptysis in a Patient With Right Lower Lobe Opacity.

Cyclical Hemoptysis in a Patient With Right Lower Lobe Opacity.

Journal: CHEST pulmonary

Published: August 04, 2026

Salvage Pneumonectomy for Rapidly Progressive Destroyed Lung during Durvalumab Maintenance after Chemoradiotherapy.

Salvage Pneumonectomy for Rapidly Progressive Destroyed Lung during Durvalumab Maintenance after Chemoradiotherapy.

Journal: Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia

Published: June 10, 2026

DIAGNOSIS OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-NEGATIVE EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS BASED ON RENAL PATHOLOGICAL FINDINGS WITHOUT ASTHMA

DIAGNOSIS OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-NEGATIVE EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS BASED ON RENAL PATHOLOGICAL FINDINGS WITHOUT ASTHMA

Journal: Arerugi = [Allergy]

Published: April 12, 2026

Biweekly carboplatin plus nab-paclitaxel with concurrent radiotherapy followed by durvalumab consolidation for unresectable locally advanced non-small cell lung cancer: a real-world retrospective cohort study.

Biweekly carboplatin plus nab-paclitaxel with concurrent radiotherapy followed by durvalumab consolidation for unresectable locally advanced non-small cell lung cancer: a real-world retrospective cohort study.

Journal: Translational lung cancer research

Published: February 09, 2026

Reversible ST-T Segment Changes Induced by Anamorelin: A Case Report.

Reversible ST-T Segment Changes Induced by Anamorelin: A Case Report.

Journal: Respirology case reports

Published: August 24, 2025

The gut microbiota as a potential biomarker in patients with EGFR-mutant lung cancer.

The gut microbiota as a potential biomarker in patients with EGFR-mutant lung cancer.

Journal: Scientific reports

Published: May 16, 2025

Association Between Baseline Neutrophil Count and Febrile Neutropenia Following Docetaxel and Ramucirumab With Prophylactic Pegfilgrastim.

Association Between Baseline Neutrophil Count and Febrile Neutropenia Following Docetaxel and Ramucirumab With Prophylactic Pegfilgrastim.

Journal: Thoracic cancer

Published: April 05, 2025

PD-L1 expression on tumor cells and tumor-infiltrating immune cells in thymic epithelial tumors detected with SP142 and SP263 antibodies.

PD-L1 expression on tumor cells and tumor-infiltrating immune cells in thymic epithelial tumors detected with SP142 and SP263 antibodies.

Journal: PloS one

Published: March 24, 2025

Efficacy of EGFR tyrosine kinase inhibitors in patients with non-small cell lung cancer with EGFR exon 19 insertions: clinical-genomic, preclinical analysis through LC-SCRUM-Asia (multi-institutional genomic screening registry).

Efficacy of EGFR tyrosine kinase inhibitors in patients with non-small cell lung cancer with EGFR exon 19 insertions: clinical-genomic, preclinical analysis through LC-SCRUM-Asia (multi-institutional genomic screening registry).

Journal: Lung cancer (Amsterdam, Netherlands)

Published: January 13, 2025

Mycobacterium goodii pulmonary disease in an immunocompetent patient: A case report and literature review.

Mycobacterium goodii pulmonary disease in an immunocompetent patient: A case report and literature review.

Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

Published: December 17, 2024

[Retracted] Predictors of efficacy of anamorelin in patients with non‑small cell lung cancer and cachexia: A retrospective study.

[Retracted] Predictors of efficacy of anamorelin in patients with non‑small cell lung cancer and cachexia: A retrospective study.

Journal: Oncology letters

Published: April 08, 2024

Highly sensitive and accurate detection of ALK-TKI resistance mutations by oligoribonucleotide interference-PCR (ORNi-PCR)-based methods.

Highly sensitive and accurate detection of ALK-TKI resistance mutations by oligoribonucleotide interference-PCR (ORNi-PCR)-based methods.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: March 13, 2024

Showing 1-12 of 46

Last Updated: 09/26/2026